Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Strong sales increase for connected mobile health devices

Still a minority market in Europe but demand is rising

Digital pharmaNew European data on connected mobile health devices shows that, although the market is still relatively small, sales have increased rapidly over the last 12 months.  

In the UK, Germany, France and the Netherlands the number of mobile-connected blood pressure monitors purchased last year rose by 42 per cent, according GfK.  

The research firm found that France led the way with connected blood pressure monitors claiming a 17.4 per cent share of the blood pressure monitor market.  

Meanwhile, sales of connected personal weighing scales rose by 88 per cent, with a 6.3 per cent value share in Germany and a respectable 12.1 per cent in the Netherlands.  

Overall, however, GfK found that connected devices currently account for only a small part of the market at present – just 5.5 per cent of the total value of blood pressure monitors sold across the four countries in 2013 and 3.3 per cent of connected personal scales.  

Udo Jansen, a global director at GfK, said: “With 2014 being the year of 'mobile health' as well as wearable technology devices, the popular media buzz around these topics is likely to have a positive effect on consumers' awareness of the potential benefits on offer.”

19th February 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics